437 related articles for article (PubMed ID: 24856785)
1. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
[TBL] [Abstract][Full Text] [Related]
2. Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.
Braun LJ; Tyagi A; Perkins S; Carpenter J; Sylvester D; Guy M; Kristensen D; Chen D
Vaccine; 2009 Jan; 27(1):72-9. PubMed ID: 18973782
[TBL] [Abstract][Full Text] [Related]
3. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.
Clausi AL; Merkley SA; Carpenter JF; Randolph TW
J Pharm Sci; 2008 Jun; 97(6):2049-61. PubMed ID: 17879291
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.
Mensch CD; Davis HB; Blue JT
PDA J Pharm Sci Technol; 2015; 69(4):477-98. PubMed ID: 26242785
[TBL] [Abstract][Full Text] [Related]
6. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
[TBL] [Abstract][Full Text] [Related]
7. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.
Egan PM; Belfast MT; Giménez JA; Sitrin RD; Mancinelli RJ
Vaccine; 2009 May; 27(24):3175-80. PubMed ID: 19446188
[TBL] [Abstract][Full Text] [Related]
10. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
Maa YF; Zhao L; Payne LG; Chen D
J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
[TBL] [Abstract][Full Text] [Related]
12. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q
PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the freeze sensitivity of a hepatitis B vaccine.
Chen D; Tyagi A; Carpenter J; Perkins S; Sylvester D; Guy M; Kristensen DD; Braun LJ
Hum Vaccin; 2009; 5(1):26-32. PubMed ID: 18971625
[TBL] [Abstract][Full Text] [Related]
14. Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.
Saini V; Sahoo MK; Murthy PK; Kohli D
Vaccine; 2009 Apr; 27(17):2372-8. PubMed ID: 19428853
[TBL] [Abstract][Full Text] [Related]
15. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.
Thakkar SG; Ruwona TB; Williams RO; Cui Z
Hum Vaccin Immunother; 2017 Apr; 13(4):936-946. PubMed ID: 28051903
[TBL] [Abstract][Full Text] [Related]
16. Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.
Clausi A; Cummiskey J; Merkley S; Carpenter JF; Braun LJ; Randolph TW
J Pharm Sci; 2008 Dec; 97(12):5252-62. PubMed ID: 18398901
[TBL] [Abstract][Full Text] [Related]
17. A heat-stable hepatitis B vaccine formulation.
Jezek J; Chen D; Watson L; Crawford J; Perkins S; Tyagi A; Jones-Braun L
Hum Vaccin; 2009 Aug; 5(8):529-35. PubMed ID: 19556877
[TBL] [Abstract][Full Text] [Related]
18. Influence of formulation pH and suspension state on freezing-induced agglomeration of aluminum adjuvants.
Salnikova MS; Davis H; Mensch C; Celano L; Thiriot DS
J Pharm Sci; 2012 Mar; 101(3):1050-62. PubMed ID: 22113733
[TBL] [Abstract][Full Text] [Related]
19. Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®.
Schlegl R; Weber M; Wruss J; Low D; Queen K; Stilwell S; Lindblad EB; Möhlen M
Vaccine; 2015 Nov; 33(44):5989-96. PubMed ID: 26095510
[TBL] [Abstract][Full Text] [Related]
20. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
